News and Announcements
iSentric (ASX: ICU) Set To Dominate The Market In 2018
- Published November 03, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
KEY TAKEAWAYS:
- iSentric proved its strong financial position through positive Q1 results that reflected strong performance not just over the quarter gone by but also during the forthcoming quarters.
- The company’s subsidiaries intend to launch new products during the forthcoming quarters and expected to add to the company’s revenue.
- iSentric intends to complete the take-over sometime during the next quarter.
For iSentric, it was another quarter of positive growth and strong performance that came to an end in September, thus laying the ground work for future. Much of the contribution towards the US $1.7 million came from Arte Mobile and Enterprise Mobility, the former being the representative of iSentric in the digital media segment in Indonesia.
Over the coming months, iSentric expects to boost its current performance further as the acquisition of MyPlay will have been completed by the closing of the next quarter. As per the management, contribution to cash-flow made by MyPlay subsequent to its take-over should have a positive impact on the balance sheet of the company.
Among the other subsidiaries, Arte Mobile of Indonesia experienced a surge in revenue courtesy of a sudden increase in new subscribers. It is also launching new products pertaining to the segment and expects that the move will further trigger an increase in subscriber base. Likewise, Enterprise Mobility, which operates in Malaysia, is hoping to launch its mobile wallet sometime in the forthcoming quarter and experience a significant increase in revenue.
Owing to the two branches of the company doing well, iSentric hopes to consolidate its position over the next quarters although MyPlay still remains a mystery. Further news pertaining to the acquisition and performance of this subsidiary will be revealed on November 24th, 2017, by the management during the Annual General Meeting.
About iSentric Limited (ASX: ICU)
iSentric (ASX: ICU) is a diversified digital services company that focuses on the high growth internet industry in South East Asia.
Company Updates
500 Million Episodes, Limited Treatment: How Patrys is Bridging the Gap in an Underserved Market
In the clinical vocabulary of the Intensive Care Unit, there is perhaps no word that carries as much quiet dread as delirium. It is a “chemical storm” of the brain—an acute dysfunction where the delicate balance between calming and activating signals is scrambled. For the patient, it can be a waking nightmare of hallucinations and […]
The Light Fantastic: Why Invion’s Photodynamic Therapy May Be Attracting Big Pharma’s Attention
Invion Limited is challenging the status quo in oncology with its Photosoft™ platform, a precision therapy that uses light-activated molecules to selectively target cancer cells. By transforming the body’s own immune response and addressing the high costs of current cancer treatments, Invion is positioning itself as a transformative player in the biotech sector. With clinical trials underway and strong institutional partnerships, the company is bridging the gap between scientific breakthrough and accessible, scalable patient care.
From Outback to Boardroom: How SWAN Systems is Codifying Water Stewardship
From the arid deserts of Australia to the boardrooms of global tech giants, SWAN Systems is redefining water efficiency. By bridging the gap between field-level agronomics and autonomous irrigation control, the company is proving that “water-positive” targets can be met with science, data, and a 10x ROI commitment.
Backed By Leading Investment Groups and Family Offices
